Astellas Pharma
4503.T
$10.03
Share price
0.85%
Change (1 day)
-9.81%
Change (1 year)
Categories
Astellas Pharma (4503.T) - Cash on Hand
Cash on Hand as of March 2025 : $1.45 Billion USD
According to Astellas Pharma's latest financial reports the company has $1.45 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Astellas Pharma - Cash on Hand chart (from 2009 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-03-31 | $2.40 B | -19.06% |
| 2023-03-31 | $2.97 B | 7.37% |
| 2022-03-31 | $2.77 B | -7.51% |
| 2021-03-31 | $2.99 B | -1.79% |
| 2020-03-31 | $3.04 B | 7.91% |
| 2019-03-31 | $2.82 B | -12.98% |
| 2018-03-31 | $3.24 B | 1.93% |
| 2017-03-31 | $3.18 B | -4.29% |
| 2016-03-31 | $3.32 B | -12.45% |
| 2015-03-31 | $3.80 B | -8.05% |
| 2014-03-31 | $4.13 B | 23.43% |
| 2013-03-31 | $3.35 B | -7.83% |
| 2012-03-31 | $3.63 B | 71.36% |
| 2011-03-31 | $2.12 B | -62.95% |
| 2010-03-31 | $5.72 B | 9.9% |
| 2009-03-31 | $5.20 B | -1.71% |
| 2008-03-31 | $5.29 B | 14.31% |
| 2007-03-31 | $4.63 B | -14.57% |
| 2006-03-31 | $5.42 B | 34.04% |
| 2005-03-31 | $4.04 B | 17.57% |
| 2004-03-31 | $3.44 B |